Genzyme announces collaboration to develop new malaria treatments
This article was originally published in Scrip
Executive Summary
The US biotechnology company Genzymeand the Medicines for Malaria Venture (MMV) have announced a collaboration with India's Advinus Therapeutics, to research and develop new treatments for malaria.